Placebo to MK-1167, MK-1167, MK-1167, MK-1167
MK-1167-008
Phase 2 small_molecule active
Quick answer
Placebo to MK-1167, MK-1167, MK-1167, MK-1167 for Alzheimer’s disease dementia is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Alzheimer’s disease dementia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active